Thelansis

Chronic Insomnia Market Outlook Thelansis’s “Chronic Insomnia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Insomnia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insights...

  Chronic Insomnia Market Outlook Thelansis’s “Chronic Insomnia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Insomnia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Chronic Insomnia Overview Chronic insomnia is a sleep disorder defined by persistent difficulty falling or staying asleep, or waking too early, for at least three months, which leads to daytime consequences like fatigue and attention deficits. A combination of factors contributes to its onset, including difficulty coping with stress, habitual light sleeping, specific personality traits, and psychosocial stressors. It is often associated with psychiatric ...

  Chronic insomnia, characterized by difficulty falling, staying, and waking too early, persists for at least three months, leading to daytime consequences such as fatigue and attention deficits. Certain factors increase the likelihood of developing chronic insomnia, including difficulty coping with stress, habitual light sleeping, and various psychiatric and medical conditions. Childhood developmental issues, specific personality traits, and psychosocial stressors also contribute to its onset. Psychiatric disorders like depression, anxiety, and post-traumatic stress disorder are often associated with chronic insomnia, as are medical conditions like restless legs syndrome, chronic pain, and GERD. Additionally, certain medications, including benzodiazepines and melatonin receptor agonists, are prescribed to manage insomnia, with cognitive behavioral therapy for insomnia (CBT-I) considered the gold standard treatment. Chronic insomnia is particularly prevalent among older individua...